Critical role of activation-inducible lymphocyte immunomediatory molecule/inducible costimulator in the effector function of human T cells: A comparative in vitro study of effects of its blockade and CD28 blockade in human beings and monkeys

Human Immunology

Volumn 69, Issue 7, 2008, Pages 399-408

  Tajima, Nobuyuki ^a   Tezuka, Katsunari ^a   Tanaka, Masaru ^a   Tanimoto, Minako ^a   Miyai, Atsuko ^a   Takeshima, Hiroaki ^a   Watanabe, Yoshihiro ^a  

^a JAPAN TOBACCO INC   (Japan)

Author keywords

CD28; Costimulatory molecule; Human; ICOS; Monkey

Indexed keywords

ANTIBODY; CD28 ANTIGEN; JTA 009;

ACTIVATION INDUCIBLE LYMPHOCYTE IMMUNOMEDIATORY MOLECULE; ALLOIMMUNITY; ARTICLE; CELL FUNCTION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; INDUCIBLE COSTIMULATOR; MOLECULE; MONKEY; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, BLOCKING; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CYTOTOXICITY, IMMUNOLOGIC; HAPLORHINI; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MICE; SPECIES SPECIFICITY; T-LYMPHOCYTE SUBSETS;

EID: 51749088771     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.05.002     Document Type: Article

References (43)

1. Rudd C.E., and Schneider H. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signaling. Nat Rev Immunol 3 (2003) 544
2. Riley J.L., and June C.H. The CD28 family: A T-cell rheostat for therapeutic control of T-cell activation. Blood 105 (2005) 13
3. Kremer J.M., Westhovens R., Leon M., Di Giorgio E., Alten R., Steinfeld S., et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 349 (2003) 1907
4. Tamatani T., Tezuka K., and Hanzawa-Higuchi N. AILIM/ICOS: A novel lymphocyte adhesion molecule. Int Immunol 12 (2000) 51
5. Tezuka K., Tsuji T., Hirano D., Tamatani T., Sakamaki K., Kobayashi Y., and Kamada M. Identification and characterization of rat AILIM/ICOS, a novel T-cell costimulatory molecule, related to the CD28/CTLA4 family. Biochem Biophys Res Commun 276 (2000) 335
6. Swallow M.M., Wallin J.J., and Sha W.C. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. Immunity 11 (1999) 423
7. Yoshinaga S.K., Whoriskey J.S., Khare S.D., Sarmiento U., Guo J., Horan T., et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature 402 (1999) 827
8. Aicher A., Hayden-Ledbetter M., Brady W.A., Pezzutto A., Richter G., Magaletti D., et al. Characterization of human inducible costimulator ligand expression and function. J Immunol 164 (2000) 4689
9. Nakazawa K., Dotan I., Brimnes J., Allez M., Shao L., Tsushima F., et al. The expression and function of costimulatory molecules B7h and B7-H1 on colonic epithelial cells. Gastroenterology 126 (2004) 134
10. Kosuge H., Suzuki J., Haraguchi G., Koga N., Maejima Y., Inobe M., et al. Critical role of inducible costimulator signaling in the development of arteriosclerosis. Arterioscler Thromb Vasc Biol 26 (2006) 2660
11. Khayyamian S., Hutloff A., Buchner K., Grafe M., Henn V., Kroczek R.A., and Mages H.W. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. Proc Natl Acad Sci U S A 99 (2002) 6198
12. Carreno B.M., and Collins M. The B7 family of ligands and its receptors. Annu Rev Immunol 20 (2002) 29
13. Coyle A.J., Lehar S., Lloyd C., Tian J., Delaney T., Manning S., et al. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 13 (2000) 95
14. Yi-qun Z., Joost van Neerven R.J., Kasran A., de Boer M., and Ceuppens J.L. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens. Int Immunol 8 (1996) 37
15. Riley J.L., Blair P.J., Musser J.T., Abe R., Tezuka K., Tsuji T., and June C.H. ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement. J Immunol 166 (2001) 4943
16. Lohning M., Hutloff A., Kallinich T., Mages H.W., Bonhagen K., Radbruch A., et al. Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J Exp Med 197 (2003) 181
17. Liu X., Bau X.F., Wen J., Gao J.X., Liu J., Lu P., et al. B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(+) T lymphocytes in vivo. J Exp Med 194 (2001) 1339
18. Hutloff A., Dittrich A.M., Beier K.C., Eljaschewitsch B., Kraft R., Anagnostopoulos I., and Kroczek R.A. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397 (1999) 263
19. Dong C., Juedes A.E., Temann U.A., Shresta S., Allison J.P., Ruddle N.H., and Flavell R.A. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 409 (2001) 97
20. Nurieva R.I., Treuting P., Duong J., Flavell R.A., and Dong C. Inducible costimulator is essential for collagen-induced arthritis. J Clin Invest 111 (2003) 701
21. Tafuri A., Shahinian A., Bladt F., Yoshinagak S.K., Jordana M., Wakeham A., et al. ICOS is essential for effective T-helper-cell responses. Nature 409 (2001) 105
22. McAdam A.J., Greenwald R.J., Levin M.A., Chernova T., Malenkovich N., Ling V., et al. ICOS is critical for CD40-mediated antibody class switching. Nature 409 (2001) 102
23. Gonzalo J.A., Tian J., Delaney T., Corcoran J., Rottman J.B., Lora J., et al. ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses. Nat Immunol 2 (2001) 597
24. Iwai H., Kozono Y., Hirose S., Akiba H., Yagita H., Okumura K., et al. Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation. J Immunol 169 (2002) 4332
25. Ozkaynak E., Gao W., Shemmeri N., Wang C., Gutierrez-Ramos J.C., Amaral J., et al. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol 2 (2001) 591
26. Guo L., Li X.K., Funeshima N., Fujino M., Nagata Y., Kimura H., et al. Prolonged survival in rat liver transplantation with mouse monoclonal antibody against an inducible costimulator (ICOS). Transplantation 73 (2002) 1027
27. Nanji S.A., Hancock W.W., Anderson C.C., Adams A.B., Luo B., Schur C.D., et al. Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival. Am J Transplant 4 (2004) 526
28. Ogawa S., Nagamatsu G., Watanabe M., Watanabe S., Hayashi T., Horita S., et al. Opposing effects of anti-activation-inducible lymphocyte-immunomodulatory molecule/inducible costimulator antibody on the development of acute versus chronic graft-versus-host disease. J Immunol 167 (2001) 5741
29. Taylor P.A., Panoskaltsis-Mortari A., Freeman G.J., Sharpe A.H., Noelle R.J., Rudensky A.Y., et al. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells downregulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM). Blood 105 (2005) 3372
30. Mendez M.J., Green L.L., Corvalan J.R., Jia X.C., Maynard-Currie C.E., Yang X.D., et al. Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat Genet 15 (2007) 146
31. Sakamoto S., Tezuka K., Tsuji T., Hori N., and Tamatani T. AILIM/ICOS: Its expression and functional analysis with monoclonal antibodies. Hybrid Hybridomics 20 (2001) 293
32. McAdam A.J., Chang T.T., Lumelsky A.E., Greenfield E.A., Boussiotis V.A., Duke-Cohan J.S., et al. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. J Immunol 165 (2000) 5035
33. Liang L., and Sha W.C. The right place at the right time: Novel B7 family members regulate effector T cell responses. Curr Opin Immunol 14 (2002) 384
34. McAdam A.J., Schweitzer A.N., and Sharpe A.H. The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells. Immunol Rev 165 (1998) 231
35. Yoshinaga S.K., Zhang M., Pistillo J., Horan T., Khare S.D., Miner K., et al. Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS. Int Immunol 12 (2000) 1439
36. Rottman J.B., Smith T., Tonra J.R., Ganley K., Bloom T., Silva R., et al. The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat Immunol 2 (2001) 605
37. Vieira P.L., Wassink L., Smith L.M., Nam S., Kingsbury G.A., Gutierrez-Ramos J.C., et al. ICOS-mediated signaling regulates cytokine production by human T cells and provides a unique signal to selectively control the clonal expansion of Th2 helper cells. Eur J Immunol 34 (2004) 1282
38. Bejarano M.T., de Waal Malefyt R., Abrams J.S., Bigler M., Bacchetta R., de Vries J.E., and Roncarolo M.G. Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. Int Immunol 4 (1992) 1389
39. Gao Q., Chen N., Rouse T.M., and Field E.H. The role of interleukin-4 in the induction phase of allogeneic neonatal tolerance. Transplantation 62 (1996) 1847
40. Chai J.G., Vendetti S., Bartok I., Schoendorf D., Takacs K., Elliott J., et al. Critical role of costimulation in the activation of naive antigen-specific TCR transgenic CD8+ T cells in vitro. J Immunol 163 (1999) 1298
41. Yu X.-Z., Ling Y., Nurieva R.I., Guo F., Anasetti C., and Dong C. Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells. J Immunol 176 (2006) 7394
42. Harada H., Salama A.D., Sho M., Izawa A., Sandner S.E., Ito T., et al. The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. J Clin Invest 112 (2003) 234
43. Kosuge H., Suzuki J., Gotoh R., Koga N., Ito H., Isobe M., et al. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway. Transplantation 75 (2003) 1374